Default Mode Network Connectivity and Nocebo Responses in Migraine: A Functional MRI Study
Abstract
Abstract Background Migraine patients are prone to nocebo responses, that hinder treatment adherence. Identifying neurobiological markers of nocebo proneness could help predict and mitigate these adverse effects. Methods This prospective three-arm randomized explorative trial examined default mode network (DMN) connectivity changes during the interictal state and an anxiety-induced nocebo challenge. Forty migraine patients were recruited (October 2019- February 2023) from Aeginition Hospital Headache Clinic, National and Kapodistrian University of Athens. All underwent baseline MRI and resting-state-fMRI (rs- f MRI) before randomization to: Experiment A, intravenous saline plus a negative verbal suggestion (“you might feel numbness”); Experiment B, negative verbal suggestion only; or Experiment C, no intervention. After 30 minutes, participants reported whether they experienced numbness, followed by a second rs-fMRI scan. Nocebo-proneness (Q-No > 15), indicated susceptibility. Four participants were excluded due to motion artifacts, leaving 36 for analysis. Results Five participants (13.8%) exhibited a nocebo response (Experiment A, n = 3; Experiment B, n = 2). Overall, responders did not differ from non-responders in DMN connectivity. Compared with non-responders with Q-No
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.